logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Haohai Biological Technology (06826.HK) repurchased 35,000 shares for HK$558,900 on October 26.

date
26/10/2026
Zhitong Finance APP News, Haohai Biological Technology (06826.HK) announced that on October 26, 2026, it spent HKD 558,900 to repurchase 35,000 shares.
Latest
2 m ago
China Boton (03318.HK) repurchased 1.286 million shares for HK$4.1074 million on October 26.
3 m ago
Southbound funds recorded a net sell of HK$2.075 billion today.
3 m ago
Zhangjiang Hi-Tech: Net profit in Q3 2026 was 164 million yuan, down 33.70% year on year.
3 m ago
Shengtai Group: Net profit loss of 12.0142 million yuan in Q3 2026, turning from profit to loss year-on-year.
4 m ago
Xiamen Tungsten: Plans to sign a framework agreement for daily related-party transactions with Zhonglan High-Tech
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.